This Clinical Investigation Assesses the Safety and Performance of a New Beamformer for MED-EL Cochlear Implant Recipients.

Cochlear implants help individuals with hearing loss by delivering electrical signals directly to the auditory nerve, bypassing damaged parts of the ear. While they significantly improve speech perception in quiet environments and over the telephone, challenges remain in noisy environments due to interference from background noise. To address this, advancements in signal-processing strategies, microphone technology, and noise-reduction algorithms have been introduced. The focus of the study is on two new front-end features: * Focused Beamformer - Enhances directional hearing. * AI Mode Medium - Utilizes the adaptive intelligence for optimized sound processing.

NCT Number	NCT07213505
Lead Sponsor	MED-EL Elektromedizinische Geräte GesmbH Collaborators: Medizinische Universität Innsbruck, Universitätsklinik für Hör-, Stimm-, und Sprachstörungen, Universitätsklinikum St. Pölten - NÖ Landeskliniken, Universitätsklinikum für Hals-, Nasen-, Ohrenkrankheiten
Conditions	Cochlear Implant Users
Enrollment	40 participants
Start Date	2025-09-29
Primary Completion	2026-06-11 (estimated)
Study Completion	2026-06-11 (estimated)
Updated on ClinicalTrials.gov	2026-06-12